- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
National Pharmaceutical Council Appoints Dr. Sharon Phares as Chief Scientific Officer
The National Pharmaceutical Council (NPC), a health policy research organization dedicated to the advancement of good evidence, science and medical innovation, announced the appointment of Sharon Phares, PhD, MPH, as chief scientific officer.
Press Release
Washington, D.C. – January 4, 2022 – The National Pharmaceutical Council (NPC), a health policy research organization dedicated to the advancement of good evidence, science and medical innovation, today announced the appointment of Sharon Phares, PhD, MPH, as Chief Scientific Officer. Dr. Phares will replace Robert W. Dubois, MD, PhD, who is retiring from NPC at the end of February 2022.
Dr. Phares, who assumes the role today, will direct NPC’s research strategy and oversee the organization’s research on policy issues, including demystifying pharmaceutical pricing perceptions, addressing challenges of health technology assessments, and examining underlying issues of patient access and affordability.
Prior to joining NPC, Dr. Phares was the Senior Vice President of Research at Pharmaceutical Strategies Group (PSG), an EPIC company, where she developed and managed all research efforts, transforming research objectives into study designs, analytic plans, and survey tools, and translating research findings into actionable information to support both internal and external clients. She also serves as an Adjunct Assistant Professor of Medicine at the Washington University School of Medicine in St. Louis.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
Advancing Integrated Care for Comorbid Schizophrenia and Substance Use Disorder
February 11th 2025Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid schizophrenia and substance use disorder.
Read More
